MedPath
NMPA Approval

Olopatadine Hydrochloride Eye Drops

国药准字H20193095

November 8, 2023

Drug Information

盐酸奥洛他定滴眼液

贝润宁

眼用制剂

0.1%(5ml:5mg,以C₂₁H₂₃NO₃计)

化学药品

November 8, 2023

Company Information

Applicant Company

浙江省金华市婺城区白汤下线高畈段58号X02幢办公质检楼二楼

Manufacturing Company

浙江省金华市工业园区金衢路368号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸奥洛他定滴眼液 - NMPA 批准文号 | MedPath